QUEENS VILLAGE, N.Y. (PRWEB) March 13, 2018
DSS Urology announced today that Dr. David S. Schnapp received recognition as a Rezūm® Center of Excellence for his expertise in treating benign prostatic hyperplasia (BPH), or enlarged prostate. Dr. Schnapp surpassed the milestone of treating 100 patients with the Rezūm® System, providing improved quality of life for men suffering from lower urinary tract symptoms caused by BPH. The Rezūm System is a revolutionary, safe and cost-effective minimally invasive treatment option for men suffering from BPH that does not require general anesthesia and provides an alternative to a lifetime of taking BPH medications. Dr. Schnapp, a board-certified urologist, offers Rezūm as an in-office BPH treatment option in Queens Village and Melville, NY, and is dedicated to bringing his patients new BPH therapies that preserve sexual function and offer a rapid return to normal activities.
BPH, or an enlarged prostate gland, is one of the top 10 most common and costly diseases affecting 14 million American men aged 50 or older, with nearly one million new diagnoses each year. BPH causes significant quality of life issues including lack of sleep, anxiety, challenges with sexual function and limits to daily activities.
Developed by NxThera, Rezūm is performed in a clinic or out-patient setting. Rezūm uses the natural thermal energy stored in water vapor, or steam, to treat the enlarged and obstructive prostate tissue that causes BPH symptoms such as frequency, urgency, irregular flow, weak stream, straining and getting up at night to urinate. The water vapor is delivered into the targeted prostate tissue and when the vapor contacts the tissue it condenses, releasing the stored thermal energy, causing the obstructive prostate tissue cells to die. In the weeks following a Rezūm procedure, the body’s natural healing response eliminates the treated tissue, shrinking the prostate. As the extra tissue is removed, the urethra opens back up, reducing BPH symptoms and improving the patient’s quality of life. Studies have shown that the Rezūm treatment provides durable symptom relief and allows men to retain sexual function unlike surgical BPH treatments, which typically have higher incidences of long-term sexual side effects. To date, more than 20,000 men have been effectively treated with the Rezūm System across the U.S. and Europe.
“Before Rezūm I was treated with two different BPH medications. I was urinating very frequently which negatively affected my lifestyle. After Rezūm my symptoms completely resolved and I no longer needed to take the BPH medications. I am extremely happy I did it,” said patient Jack Hamrick.
“Our goal is to transform the lives of BPH patients across the country with the Rezūm System,” said Bob Paulson, president and CEO of NxThera. “With Dr. Schnapp’s expertise and advanced training with Rezūm, patients suffering from BPH in the New York City and Long Island area now have a minimally invasive, lasting and cost-effective alternative for the treatment of BPH so they can get back to enjoying a better quality of life.”
Highlights of the Rezūm therapy include:
- Performed in-office and patients can return home immediately.
- Does not require general anesthesia.
- Relieves symptoms safely and effectively.
- Is an alternative to BPH medications, eliminating the need for long-term BPH medication use.
- Provides noticeable symptom improvement within two weeks.
- Preserves erectile and urinary functions.
- Allows patients to return to regular activities within a few days.
- Considered medically necessary by Medicare and covered by most private insurance payers.
Patients interested in a consultation with Dr. Schnapp should call 718-479-5017 for the Queens Village, Queens office or 631-629-4949 for the Melville office, or email rezuminfo(at)dssurology(dot)com to schedule an appointment.
About DSS Urology
DSS Urology was founded by Dr. David S. Schnapp in 2000. DSS Urology is a center of excellence for urologic care with an emphasis on minimally invasive procedures and a wide variety of surgical techniques. We seek growth not only on the reputation of our physicians, but on the tireless dedication and service of our staff.
About NxThera and the Rezūm System
NxThera pioneered its Convective Water Vapor Energy (WAVE®) platform technology to treat a variety of endourological conditions, beginning with BPH. The company is conducting advanced development and clinical research to potentially expand application of its technology to include the targeted treatment of cancerous prostate, kidney and bladder tissue as well as OAB. NxThera’s FDA-cleared Rezūm System is indicated to treat symptoms of BPH using thermal energy that is convectively delivered to obstructive prostate tissue in targeted, precise treatments, with minimal discomfort. Three-year clinical data demonstrates sustained improvements in LUTS, urine flow, quality of life, and preservation of sexual function. Founded in 2008, NxThera is located in Maple Grove, Minn. For more information, visit http://www.Rezūm.com.